Nucleophosmin regulates the stability and transcriptional activity of p53

被引:438
作者
Colombo, E
Marine, JC
Danovi, D
Falini, B
Pelicci, PG
机构
[1] European Inst Oncol, Dept Expt Oncol, I-20141 Milan, Italy
[2] Univ Perugia, Inst Haematol, I-06100 Perugia, Italy
[3] Univ Perugia, Inst Internal Med, I-06100 Perugia, Italy
[4] FIRC Inst Mol Oncol, I-20141 Milan, Italy
关键词
D O I
10.1038/ncb814
中图分类号
Q2 [细胞生物学];
学科分类号
071009 ; 090102 ;
摘要
Nucleophosmin (NPM) is a ubiquitously expressed nucleolar phosphoprotein that continuously shuttles between the nucleus and cytoplasm(1). It has been proposed to function in ribosomal protein assembly and transport(2), and also as a molecular chaperone that prevents proteins from aggregating in the crowded environment of the nucleolus(3). The NPM gene is involved in several tumour-associated chromosome translocations, which have resulted in the formation of fusion proteins that retain the amino terminus of NPM, including NPM-ALK(4), NPM-RAR(5) and NPM-MLF1 (ref. 6). It is generally thought that the NPM component is not involved in the transforming potential of these fusion proteins(7), but instead provides a dimerization interface for the oligomerization and the oncogenic conversion of the various NPM partners (ALK, RAR, MLF1). Here we show that NPM interacts directly with the tumour suppressor p53, regulates the increase in stability and transcriptional activation of p53 after different types of stress, and induces p53-dependent premature senescence on overexpression in diploid fibroblasts. These findings indicate that NPM is a crucial regulator of p53 and suggest that alterations of the NPM function by NPM fusion proteins might lead to deregulation of p53 in tumours.
引用
收藏
页码:529 / 533
页数:5
相关论文
共 29 条
[1]   p53-dependent apoptosis or growth arrest induced by different forms of radiation in U2OS cells:: p21WAF1/CIP1 repression in UV induced apoptosis [J].
Allan, LA ;
Fried, M .
ONCOGENE, 1999, 18 (39) :5403-5412
[2]   Role of the nucleophosmin (NPM) portion of the non-Hodgkin's lymphoma-associated NPM-anaplastic lymphoma kinase fusion protein in oncogenesis [J].
Bischof, D ;
Pulford, K ;
Mason, DY ;
Morris, SW .
MOLECULAR AND CELLULAR BIOLOGY, 1997, 17 (04) :2312-2325
[3]   MAJOR NUCLEOLAR PROTEINS SHUTTLE BETWEEN NUCLEUS AND CYTOPLASM [J].
BORER, RA ;
LEHNER, CF ;
EPPENBERGER, HM ;
NIGG, EA .
CELL, 1989, 56 (03) :379-390
[4]   Detection of normal and chimeric nucleophosmin in human cells [J].
Cordell, JL ;
Pulford, KAF ;
Bigerna, B ;
Roncador, G ;
Banham, A ;
Colombo, E ;
Pelicci, PG ;
Mason, DY ;
Falini, B .
BLOOD, 1999, 93 (02) :632-642
[5]  
DEVERAUX Q, 1994, J BIOL CHEM, V269, P7059
[6]   A BIOMARKER THAT IDENTIFIES SENESCENT HUMAN-CELLS IN CULTURE AND IN AGING SKIN IN-VIVO [J].
DIMRI, GP ;
LEE, XH ;
BASILE, G ;
ACOSTA, M ;
SCOTT, C ;
ROSKELLEY, C ;
MEDRANO, EE ;
LINSKENS, M ;
RUBELJ, I ;
PEREIRASMITH, O ;
PEACOCKE, M ;
CAMPISI, J .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1995, 92 (20) :9363-9367
[7]   Duplexes of 21-nucleotide RNAs mediate RNA interference in cultured mammalian cells [J].
Elbashir, SM ;
Harborth, J ;
Lendeckel, W ;
Yalcin, A ;
Weber, K ;
Tuschl, T .
NATURE, 2001, 411 (6836) :494-498
[8]   WAF1, A POTENTIAL MEDIATOR OF P53 TUMOR SUPPRESSION [J].
ELDEIRY, WS ;
TOKINO, T ;
VELCULESCU, VE ;
LEVY, DB ;
PARSONS, R ;
TRENT, JM ;
LIN, D ;
MERCER, WE ;
KINZLER, KW ;
VOGELSTEIN, B .
CELL, 1993, 75 (04) :817-825
[9]   Regulation of p53 activity in nuclear bodies by a specific PML isoform [J].
Fogal, V ;
Gostissa, M ;
Sandy, P ;
Zacchi, P ;
Sternsdorf, T ;
Jensen, K ;
Pandolfi, PP ;
Will, H ;
Schneider, C ;
Del Sal, G .
EMBO JOURNAL, 2000, 19 (22) :6185-6195
[10]   THE ACUTE PROMYELOCYTIC LEUKEMIA-SPECIFIC PML-RAR-ALPHA FUSION PROTEIN INHIBITS DIFFERENTIATION AND PROMOTES SURVIVAL OF MYELOID PRECURSOR CELLS [J].
GRIGNANI, F ;
FERRUCCI, PF ;
TESTA, U ;
TALAMO, G ;
FAGIOLI, M ;
ALCALAY, M ;
MENCARELLI, A ;
GRIGNANI, F ;
PESCHLE, C ;
NICOLETTI, I ;
PELICCI, PG .
CELL, 1993, 74 (03) :423-431